What are the ESMO recommendations for treatment of locally advanced pancreatic cancer?

Updated: Oct 02, 2020
  • Author: Tomislav Dragovich, MD, PhD; Chief Editor: N Joseph Espat, MD, MS, FACS  more...
  • Print

In patients with locally advanced (unresectable) tumors, ESMO recommendations are as follows [63] :

  • The standard of care is 6 months of gemcitabine

  • Chemoradiation may have a minor role, but no regimen other than the combination of capecitabine and radiotherapy can be recommended

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!